Implementation of Onsite, Rapid ART Initiation Among People Who Inject Drugs Living With HIV at Syringe Services Program

Inclusion Criteria: 1. Adult (age\>18 years); 2. positive rapid HIV test; 3. ability to provide informed consent; 4. HIV RNA \> 200 copies/ml; 5. creatinine clearance \> 30 mg/dl as measured by serum creatinine; 6. no allergy to bictegravir/emtricitabine/tenofovir alafenamide (BFTAF) as indicated by patient history and self-reported allergies. Exclusion Criteria: 1\) Any other comorbidities at the discretion of the investigator